RAS and BRAF V600E mutation test (pathology)
RAS and BRAF V600E mutations
tests per year, UK, once, in metastatic disease
“Test for RAS and BRAF V600E mutations in all people with metastatic colorectal cancer suitable for systemic anticancer treatment.”
NICE NG151 Colorectal cancer, recommendations, 2026-11-06
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- Metastatic disease only.
Used in
Kept as evidence; no figure on the platform is computed from it yet.